KRYS vs. COOP
Compare and contrast key facts about Krystal Biotech, Inc. (KRYS) and Mr. Cooper Group Inc. (COOP).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: KRYS or COOP.
Correlation
The correlation between KRYS and COOP is 0.45, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
KRYS vs. COOP - Performance Comparison
Loading data...
Key characteristics
KRYS:
-0.30
COOP:
1.65
KRYS:
-0.22
COOP:
2.27
KRYS:
0.97
COOP:
1.28
KRYS:
-0.40
COOP:
2.64
KRYS:
-0.88
COOP:
8.29
KRYS:
17.30%
COOP:
6.38%
KRYS:
43.96%
COOP:
35.92%
KRYS:
-53.42%
COOP:
-87.08%
KRYS:
-37.04%
COOP:
-4.37%
Fundamentals
KRYS:
$4.03B
COOP:
$7.63B
KRYS:
$4.17
COOP:
$8.98
KRYS:
33.44
COOP:
13.27
KRYS:
12.08
COOP:
3.43
KRYS:
4.09
COOP:
1.55
KRYS:
$333.45M
COOP:
$2.43B
KRYS:
$308.79M
COOP:
$1.29B
KRYS:
$130.03M
COOP:
$856.00M
Returns By Period
In the year-to-date period, KRYS achieves a -14.13% return, which is significantly lower than COOP's 33.68% return.
KRYS
-14.13%
-18.47%
-28.14%
-13.11%
17.95%
N/A
COOP
33.68%
16.68%
26.83%
58.50%
72.85%
14.55%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
KRYS vs. COOP — Risk-Adjusted Performance Rank
KRYS
COOP
KRYS vs. COOP - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Krystal Biotech, Inc. (KRYS) and Mr. Cooper Group Inc. (COOP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
KRYS vs. COOP - Dividend Comparison
Neither KRYS nor COOP has paid dividends to shareholders.
Drawdowns
KRYS vs. COOP - Drawdown Comparison
The maximum KRYS drawdown since its inception was -53.42%, smaller than the maximum COOP drawdown of -87.08%. Use the drawdown chart below to compare losses from any high point for KRYS and COOP. For additional features, visit the drawdowns tool.
Loading data...
Volatility
KRYS vs. COOP - Volatility Comparison
Krystal Biotech, Inc. (KRYS) has a higher volatility of 18.92% compared to Mr. Cooper Group Inc. (COOP) at 14.10%. This indicates that KRYS's price experiences larger fluctuations and is considered to be riskier than COOP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
KRYS vs. COOP - Financials Comparison
This section allows you to compare key financial metrics between Krystal Biotech, Inc. and Mr. Cooper Group Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
KRYS vs. COOP - Profitability Comparison
KRYS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Krystal Biotech, Inc. reported a gross profit of 83.16M and revenue of 88.18M. Therefore, the gross margin over that period was 94.3%.
COOP - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Mr. Cooper Group Inc. reported a gross profit of 367.00M and revenue of 560.00M. Therefore, the gross margin over that period was 65.5%.
KRYS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Krystal Biotech, Inc. reported an operating income of 36.18M and revenue of 88.18M, resulting in an operating margin of 41.0%.
COOP - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Mr. Cooper Group Inc. reported an operating income of 106.00M and revenue of 560.00M, resulting in an operating margin of 18.9%.
KRYS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Krystal Biotech, Inc. reported a net income of 35.73M and revenue of 88.18M, resulting in a net margin of 40.5%.
COOP - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Mr. Cooper Group Inc. reported a net income of 88.00M and revenue of 560.00M, resulting in a net margin of 15.7%.